CASI Pharma (CASI) Reports Q3 Loss of $0.05
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Join SI Premium – FREE
CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.05), versus ($0.07) reported last year.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
- SpaceX receives Baa1 rating from Moody's with stable outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
